Cogent Biosciences Stock 346% Surge Fueled by New Stake
A Phase 3 breakthrough unleashed a dramatic move in Cogent Biosciences. A large fund followed with a sizable stake, s...
Determine which funds deliver the best annual risk-adjusted returns and how they stack up. Compare contenders to pick winners.
28,456 articlesA Phase 3 breakthrough unleashed a dramatic move in Cogent Biosciences. A large fund followed with a sizable stake, s...
IBM’s profit warning sharpens focus on the Dow’s direction, while technology stocks push Nasdaq higher. Here’s what t...
Two clean-energy stock contenders—EOS and Plug Power—promise very different routes to a low-carbon future. This deep ...
The memory market is famous for wild swings. This guide breaks down what Micron does, where demand may come from, and...
A Spain-Cape Verde draw triggered record payouts on Polymarket, exposing how bets branded as safe can yield outsized ...
When a founder sells a sizable stake, investors take note. This article digs into the implications of airbnb co-found...
Global stocks drift higher as talks on a U.S.-Iran peace deal gain momentum. Yet traders warn the market isn’t fully ...
AI chip headlines are steering market moves this June. From Google’s foundry ambitions to Intel's refreshed strategy,...
Oklo stock surged as investors weighed its plans for advanced reactors against the fast-moving AI data-center boom. T...
Insider activity can be a clue about a company’s path, but the motives are varied. This article dissects iradimed's s...
A major stake from Nvidia lit a fire under Nebius Group, sending Nebius stock soared today. Here's what this means fo...
Cava Group stunned investors with a standout first-quarter performance, sending the stock higher. But a quick rally d...